DBV Technologies | Fremdkapital



Loan Capital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amarin USD 0 0 2024-09
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
DBV Technologies USD 0 0 2024-09
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Incyte USD 32.64M 899K 2025-03
Insmed USD 1.13B 147.77M 2024-12
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 0 0 2025-03



DBV Technologies Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.